- Home
- VRCA vs TPCS Comparison
VRCA vs TPCS Comparison
Compare VRCA & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- TPCS
- Stock Information
- Founded
- VRCA 2013
- TPCS 1956
- Country
- VRCA United States
- TPCS United States
- Employees
- VRCA N/A
- TPCS N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- TPCS Metal Fabrications
- Sector
- VRCA Health Care
- TPCS Industrials
- Exchange
- VRCA Nasdaq
- TPCS Nasdaq
- Market Cap
- VRCA 58.7M
- TPCS 51.4M
- IPO Year
- VRCA 2018
- TPCS N/A
- Fundamental
- Price
- VRCA $5.47
- TPCS $5.03
- Analyst Decision
- VRCA Hold
- TPCS
- Analyst Count
- VRCA 5
- TPCS 0
- Target Price
- VRCA $60.00
- TPCS N/A
- AVG Volume (30 Days)
- VRCA 45.4K
- TPCS 103.5K
- Earning Date
- VRCA 08-12-2025
- TPCS 08-21-2025
- Dividend Yield
- VRCA N/A
- TPCS N/A
- EPS Growth
- VRCA N/A
- TPCS N/A
- EPS
- VRCA N/A
- TPCS N/A
- Revenue
- VRCA $14,704,000.00
- TPCS $33,424,000.00
- Revenue This Year
- VRCA $165.25
- TPCS N/A
- Revenue Next Year
- VRCA $80.06
- TPCS N/A
- P/E Ratio
- VRCA N/A
- TPCS N/A
- Revenue Growth
- VRCA 5.72
- TPCS 3.78
- 52 Week Low
- VRCA $3.82
- TPCS $2.05
- 52 Week High
- VRCA $30.19
- TPCS $6.25
- Technical
- Relative Strength Index (RSI)
- VRCA 38.26
- TPCS 53.20
- Support Level
- VRCA $5.77
- TPCS $5.00
- Resistance Level
- VRCA $7.40
- TPCS $5.49
- Average True Range (ATR)
- VRCA 0.55
- TPCS 0.53
- MACD
- VRCA -0.06
- TPCS -0.08
- Stochastic Oscillator
- VRCA 3.25
- TPCS 12.86
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.